Sen. Chuck Grassley, R-Iowa, says the FDA should conduct unannounced inspections of foreign manufacturing facilities, particularly those in China and India, where most ingredients used in US pharmaceuticals are made. "As you are aware, I believe that drug importation will help to reduce drug costs for American consumers and patients," Grassley wrote in a letter to FDA acting Commissioner Norman Sharpless and HHS Secretary Alex Azar, but he noted his "position is predicated on the FDA ensuring the safety and efficacy of those drugs."
Grassley calls for unannounced inspection of foreign drug plants
Sign up for PCMA SmartBrief
Top news for PBMs
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.